Summary & Overview
HCPCS K0553: Supply Allowance for Therapeutic Continuous Glucose Monitor
HCPCS Level II code K0553 designates a supply allowance for therapeutic continuous glucose monitors (CGMs), covering all supplies and accessories with billing in monthly units (1 month = 1 unit). This code matters nationally as CGM use expands for insulin-treated patients and for therapeutic device programs where supply coverage affects patient access and program costs. The code aligns supply reimbursement with ongoing diabetes management and device-based therapies.
Key payers included in this overview are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what K0553 represents, the service type (durable medical equipment / disposable supplies for CGM), and typical sites of service (home and outpatient settings). The publication outlines benchmarking and coverage implications, highlights common billing modifiers referenced in payer policies, and summarizes the clinical context for therapeutic CGM supply needs. Where payer-specific policy language or utilization benchmarks are available, the report summarizes typical coverage considerations and billing practices nationally. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code K0553 describes a supply allowance for a therapeutic continuous glucose monitor (CGM). The code covers all supplies and accessories associated with the therapeutic CGM and is reported in units where 1 month supply = 1 unit of service.
Service Type: Durable medical equipment / disposable supplies related to therapeutic CGM therapy
Typical Site of Service: Outpatient and home use settings where patients use a therapeutic continuous glucose monitor, including home health and ambulatory care settings.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult or pediatric patient with insulin-dependent diabetes mellitus requiring a therapeutic continuous glucose monitor (CGM) to guide insulin dosing and glycemic management. The clinician (endocrinologist, diabetologist, or certified diabetes educator) prescribes a therapeutic CGM when frequent real-time glucose data are needed to adjust insulin pump settings, dose insulin injections, or manage recurrent hypoglycemia or hyperglycemia.
Workflow: The provider documents medical necessity, selects K0553 for the monthly supply allowance, and sends the prescription to the durable medical equipment supplier or pharmacy. The supplier dispenses a one-month supply of CGM supplies and accessories (sensors, transmitter components, adhesives, and related disposables). Follow-up visits occur at routine diabetes visits or sooner for device troubleshooting; supplies are billed monthly as units of service (1 unit = 1 month).
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when unusually complex device setup or training requires substantially greater resources than usual. |